This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Use of Tracking Devices to Locate Abnormalities During Invasive Procedures | MicrobiomeTrials
← Back to trials NCT00102544
Use of Tracking Devices to Locate Abnormalities During Invasive Procedures ENROLLING_BY_INVITATION NA INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2005-02-23Est. Completion: 2028-08-02
Enrollment target: 3,894 participantsLocations National Institutes of Health Clinical Center, Bethesda, Maryland, United States Other microbiome trials you might be interested in Locally Advanced Cervical Adenocarcinoma Locally Advanced Cervical Adenosquamous Carcinoma Locally Advanced Cervical Squamous Cell Carcinoma Stage IIIA Cervical Cancer FIGO 2018 Stage IIIB Cervical Cancer FIGO 2018 Stage IIIC1 Cervical Cancer FIGO 2018 Stage IIIC2 Cervical Cancer FIGO 2018 Stage IVA Cervical Cancer FIGO 2018
This phase III trial compares the addition of induction chemotherapy, with carboplatin, paclitaxel and pembrolizumab, to…
Birmingham, United States Est. completion Dec 31, 2030
Phase 2
Recruiting
Breast Atypical Ductal Hyperplasia Breast Atypical Lobular Hyperplasia Breast Carcinoma Breast Ductal Carcinoma In Situ Breast Lobular Carcinoma In Situ Estrogen Receptor-Positive Breast Carcinoma
This phase II trial evaluates response-guided low-dose tamoxifen for reducing breast density in women who are at higher …
Tucson, United States Est. completion Mar 31, 2028
Post-Hepatectomy Liver Failure Liver Failure Liver Neoplasms Carcinoma, Hepatocellular Liver Metastases Postoperative Complications Hepatic Congestion
Removing a large part of the liver (major hepatectomy) can cure primary and secondary liver cancers, but it carries the …
Minya, Egypt Est. completion Apr 30, 2028